闫奎坡，朱翠玲，孙彦琴，朱明军，高 原，李 彬

    ·临床医学论著·

    试以“中药复方循证生物系统研究策略”阐述当归补血汤心脏保护的研究设想

    闫奎坡，朱翠玲，孙彦琴，朱明军，高 原，李 彬

    “中药复方循证生物系统研究策略(Chinese Herbal Compound Formula Evidence-Based Biosystem Research Strategy，CHCF-EB-BRS)”是从中医古医籍、系统评价、质量控制、临床辨证治疗疗效评价、物质基础及其作用机制等多层次对中药复方进行研究，充分阐明中药复方的整体疗效学、疗效学机制及物质成分的一种研究方法。本研究提出假说，拟在CHCF-EB-BRS策略指导下阐明当归补血汤对心肌缺血的多方面疗效学研究、机制研究、物质基础的思路、设想及预期结果，从而指导实验的进一步开展，以期为中药复方研究提供一种思路。

    中药复方；循证医学；生物系统研究策略；当归补血汤；心脏保护

    Absract：Chinese herbal compound formula (CHCF) are widely used in clinic，with the development of evidence-based medicine，it has put forward a new challenge on Chinese herbal compound formula (CHCF).It has become a strategic planning to further research and develop CHCF，provide sufficient curative evidence，promote the modernization of traditional Chinese medicine，promote Chinese medicine culture，extend CHCF to the world.In this paper，the author put forward Chinese Herbal Compound Formula Evidence-Based Biosystem Research Strategy (CHCF-EB-BRS)，which conducts multi-level study of CHCF from ancient medical books，system evaluation and analysis，quality control ......